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The aim of this study was to investigate radioprotective properties of Echinacea purpurea tablets in vivo. 
We analysed lymphocyte chromosome aberrations (CA), micronuclei (MN), apoptosis of leukocytes 
and haematological parameters in a group of radiation workers who were identiﬁ ed as carrying dicentric 
chromosomes in their lymphocytes. All radiation workers were taking two 275 mg Echinacea tablets 
b.i.d., according to a pharmacist’s recommendation. All parameters were analysed before and after the 
two-week treatment. At the end of the treatment lymphocyte CA frequency dropped signiﬁ cantly, and 
the number of apoptotic cells increased. The inverse lymphocyte-to-granulocyte ratio at the beginning 
of the study changed to normal at its end. In conclusion, biological effects observed after administration 
of Echinacea purpurea preparation suggest that it may be beneﬁ cial for the prevention of adverse health 
effects in workers exposed to ionising radiation.
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Low–dose ionising radiation may affect living 
cells in three ways: 1) injured or damaged cells repair 
themselves without residual damage; 2) cells die; or 
3) cells misrepair themselves, which eventually lead 
to a structural and/or functional change.
Radiation-induced aberrations can be observed 
in human lymphocytes within a few hours from 
exposure; their frequency is related to the dose and 
type of radiation, and can be detected in blood samples 
taken long after the exposure (1). Chromosomal 
damage can indirectly be estimated by scoring 
micronuclei (MN) (2). The formation of MN in 
dividing cells is the result of unrepaired or misrepaired 
chromosomal breaks or chromosome malsegregation 
due to mitotic malfunction (3). Most MN studies have 
been using cultured peripheral lymphocytes, which 
lend themselves well to both genotoxicity testing and 
biomonitoring.
This study focused on chronic occupational 
exposure to ionising radiation. Earlier investigation has 
shown that 3 %  of radiologists occupationally exposed 
to ionising radiation carry dicentric chromosomes in 
their lymphocytes. Most of them showed a signiﬁ cantly 
decreased leukocyte ability to undergo apoptosis (4). 
Two factors blur the association between radiation 
exposure and clinical effects, that is, individual 
variability (due to genetic and environmental factors) 
and the presence of various defensive mechanisms 
which counteract to oxidative stress induced by 
irradiation (5). Current biomonitoring mostly uses 
cytogenetic markers of chromosomal aberrations 
and micronuclei in circulating lymphocytes. These 
biomarkers may be useful to identify individuals 
more vulnerable to radiation damage, and who 
might be eligible for preventive measures such as 
limiting the exposure and pharmacological or dietary 
radioprotection.
The aim of this study was to evaluate the 
radioprotective properties of Echinacea purpurea 
extracts in vivo. For this purpose, radiology technicians, 
who were identiﬁ ed as carrying dicentrics in their 
lymphocytes were asked to take Echinacea purpurea 
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tablets and were analysed for chromosome aberrations, 
micronuclei, apoptosis, and haematological parameters 
before and after the treatment.
MATERIALS AND METHODS
Study design
The exposed group included 10 radiology technicians 
identiﬁ ed as carrying dicentric chromosomes in their 
lymphocytes during routine checkups. Lymphocyte 
aberrations in these subjects were accompanied by 
mild leucopoenia and imbalance in the ratio between 
lymphocytes, monocytes, and granulocytes. Ten 
subjects, all men, were willing to take two Echinacea 
purpurea tablets (Ehinacea®, Strong Nature, Serbia) 
twice a day (b.i.d.) for two weeks. Each 275 mg tablet 
contains Echinacea purpurea dry extract standardised 
at 8.3 % of total phenolic content (calculated in terms 
of chlorogenic acid units). Echinacea preparation 
contains caffeic acid derivatives, sugar, and caffeic 
acid esters - echinacosides. Throughout the treatment, 
the 10 subject took no other drugs/preparations or 
vitamin supplements.
The average group age was (38.7±3.4) years, 
and average occupational exposure duration 
(14.6±3.4) years. The radiation doses measured by 
thermoluminescent dosimeters (TLD) on the chest 
were below the annual limit of 20 mSv (Table 1). 
Lymphocyte micronuclei, chromosomal aberrations, 
and apoptosis were analyzed at the beginning and at 
the end of treatment. This study used each subject as 
his own control.
Blood sampling
Peripheral blood samples were collected in 
heparinised vacutainers by venipuncture in accordance 
with the Declaration of Helsinki and current health 
ethics regulations in Serbia (6, 7). Venous blood was 
collected in a test tube containing an anticoagulant 
(ethylenediaminetetraacetic acid, EDTA) to prevent 
clotting. 
Blood count
The blood was mixed well (but not shaken) and 
inserted into the haematology analyzer CELL-DYN 
3700 (Abbott Laboratories, Illinois, USA) that 
recorded haemoglobin concentration, red blood cell 
(RBC), white blood cell (WBC), neutrophil (NpG), 
lymphocyte (Ly), and monocyte (Mo) counts.
Chromosomal aberration analysis
For scoring chromosomal aberrations, standard 
methods (1) were used: aliquots of heparinised whole 
blood (0.5 mL) were set up in cultures containing 
PBmax-karyotyping medium (Invitrogen-Gibco, 
Paisley, UK). Cells were harvested 48 h after initiation 
of culture. For the last three hours the cells were 
cultured in the presence of colchicine (Sigma Aldrich, 
St. Louis, MO. USA) in the ﬁ nal concentration of 
2.5 µg mL-1. Slides were prepared according to 
the standard protocol for chromosomal aberration 
analysis. After staining, 200 well-spread and 
complete ﬁ rst-division metaphases per subject were 
analysed for unstable chromosome-type aberrations, 
i.e. dicentric and rings chromosomes, and acentric 
fragments. The scoring criteria were based on the 
IAEA recommendations (1).
Micronucleus test
For the micronucleus test, aliquots of heparinised 
whole blood (0.5 mL) were set up in cultures 
Table 1 General characteristics of the ten radiology technicians exposed to <20 mSv of irradiation a year
Subject No. Age / year
Occupational exposure /
year
Smoking 
1 37 14 -
2 43 19 +
3 39 16 -
4 36 13 +
5 41 16 -
6 34 11 +
7 36 11 +
8 38 13 +
9 45 21 +
10 38 12 -
mean±S.D. 38.7±3.4 14.6±3.4
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containing PBmax-karyotyping medium (Invitrogen-
Gibco). The slides were prepared according to the 
method described by Fenech (8). At least 1000 
binucleated cells were scored per culture. Cytokinesis-
block proliferation index (CBPI) was calculated using 
the following equation:
CBPI=[MI+2MII+3(MIII+MIV)]/N,
where MI-MIV is the number of cells with one to 
four nuclei, respectively, and N is the number of cells 
scored (9).
Apoptosis of leukocytes
For the apoptosis assay, blood aliquots of 0.5 mL 
from each subject were incubated with the RPMI-1640 
medium (Invitrogen-Gibco) supplemented with 15 % 
calf serum without phytohaemagglutininin in a CO
2
 
incubator for 24 h. After incubation, cells were gently 
washed with saline (0.9 % NaCl) at 37 °C and ﬁ xed in 
methanol:acetic acid (3:1). The pellet was then ﬁ xed 
in 96 % ethanol. Apoptosis was assessed by ﬂ ow 
cytometric identiﬁ cation of cells displaying apoptosis-
associated DNA condensation. Three parameters were 
measured: cell size, granularity, and DNA content. 
DNA content was assessed by measuring the UV 
fluorescence of propidium iodide-stained DNA. 
Cytotoxicity was deﬁ ned as the population of cells 
with reduced DNA ﬂ uorescence (10). Each analysis 
included 10000 events per sample.
Statistics
Statistical analysis of each parameter was carried 
out using the statistical software package Statistica 
version 5.5 for Windows. It included the frequency 
of chromosomal aberrations and micronuclei in 
binucleated cells, leukocyte count, and absolute 
lymphocyte, granulocyte (neutrophil), and monocyte 
counts. The results were evaluated using the Spearman 
rank order correlation and Wilcoxon matched-paired 
test.
RESULTS
Table 2 and Figure 1a-c show individual data 
on haemoglobin concentration, red blood cell 
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Figure 1  Percentage of granulocytes (a), lymphocytes (b), monocytes (c), and apoptotic leukocytes (d) in radiology technicians 
before (open circle) and after a two-week treatment with Echinacea purpurea preparation (closed circle).
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(RBC), white blood cell (WBC), neutrophil (NpG), 
lymphocyte (Ly), and monocyte (Mo) counts in 
radiology technicians.
Apoptosis is expressed as the percentage of cells 
displaying apoptotic granularity (Figure 1d). The sum 
of exchange aberrations, lymphocyte micronuclei, and 
proliferation index are shown on Table 3.
At the beginning of treatment, the leukocyte 
count positively correlated with the incidence of 
chromosomal aberrations and negatively with 
Table 2  Blood count including haemoglobine (Hb), RBC, WBC, neutrophil (NpG), lymphocyte(Ly), and monocyte (Mo) count 
in radiation workers at the beginning (*) and after two weeks of treatment with Echinacea purpurea preparation(**)
Subject 
No.
Hb / g L-1 RBC / x 1012 L-1
Total WBC / 
x 109 L-1
NpG Ly Mo
* ** * ** * ** * ** * ** * **
1 140 144 5.05 5.24 8.66 6.74 4.91 4.09 3.56 2.06 0.16 0.55
2 138 139 5.27 5.23 8.17 7.70 4.14 4.18 3.60 2.50 0.36 0.95
3 167 162 4.98 4.81 7.68 6.80 4.75 3.95 2.39 2.41 0.43 0.37
4 152 160 5.21 5.11 9.33 9.44 4.06 3.15 4.70 5.69 0.49 0.50
5 151 153 4.76 4.62 5.11 5.54 1.95 1.84 2.84 3.02 0.28 0.64
6 146 153 4.29 4.37 8.73 8.51 3.75 2.92 3.91 4.73 0.98 0.78
7 139 136 4.91 4.86 3.54 5.65 1.76 3.34 1.55 1.93 0.15 0.34
8 161 158 5.62 5.48 8.67 8.30 4.21 3.61 4.04 3.90 0.36 0.72
9 164 172 5.70 5.99 5.95 4.90 3.35 1.84 2.15 2.45 0.40 0.55
10 159 164 5.12 5.26 8.22 8.33 4.56 3.85 3.26 3.90 0.31 0.48
Mean
±S.D.
151.70 
±10.77
154.10 
±11.50
5.09 
±0.41
5.10 
±0.46
7.41 
±1.89
7.19 
±1.50
3.74 
±1.10
3.28
±0.86
3.20 
±0.96
3.26 
±1.25
0.39 
±0.23
0.59 
±0.19
Table 3  Incidence of chromosome breaks, incidence of micronuclei, and proliferation index in radiation workers at the beginning 
and after two weeks of treatment with Echinacea purpurea preparation.
Subject
No.
Incidence of 
chromosome 
breakage
per cell*
Incidence 
of MN per
1000 BN 
cells
Micronuclei distribution
mBN 
cells
CBPI
Number of cells with:
0
MN
1
MN
2
MN
3
MN
1
at the 
beginning
of 
treatment
0.035 38 1153 36 3 1 3 1.94
2 0.035 40 1036 27 5 2 3 1.96
3 0.030 33 1050 24 6 0 3 1.97
4 0.025 37 1164 39 3 0 3 1.93
5 0.025 24 1552 22 8 0 2 1.98
6 0.025 32 1006 25 4 0 3 1.98
7 0.015 44 1058 34 4 2 4 1.97
8 0.015 25 1161 18 6 0 2 1.97
9 0.015 24 1193 27 1 0 2 1.93
10 0.010 16 1245 20 0 0 2 1.99
1
after two 
weeks of 
treatment
0.015 37 1191 30 5 2 3 1.95
2 0.020 37 1164 31 4 2 3 1.97
3 0.010 27 1209 33 0 0 3 1.98
4 0.000 12 1374 16 0 0 1 1.94
5 0.025 21 1185 25 0 0 2 1.97
6 0.000 29 1056 32 0 0 3 1.99
7 0.005 18 1146 9 6 0 1 1.97
8 0.000 11 1432 16 0 0 1 1.98
9 0.000 7 1314 9 0 0 1 1.94
10 0.005 34 1251 35 3 1 3 1.97
*dicentrics or rings, acentrics and chromosome breaks
mBN - binucleated cells with MN
CBPI - cytokinesis-block proliferation index
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micronuclei and apoptosis, but not at a statistically 
signiﬁ cant level.
At the end of the treatment, a statistically 
signiﬁ cant correlation was found between the absolute 
granulocyte count and micronuclei (R=0.68, P<0.05). 
An inverse correlation at the border of signiﬁ cance was 
found between the monocyte count and the percentage 
apoptotic leukocytes (R=-0.59, P<0.06).
Wilcoxon matched-pairs test showed statistically 
signiﬁ cant differences in micronucleus frequency and 
apoptotic cells between the beginning and the end of 
the treatment (Z=1.99, P<0.05 and Z=2.49, P<0.02, 
respectively). We also found a statistically signiﬁ cant 
difference between the percentage of monocytes at the 
beginning and at the end of the treatment (Z=2.09, 
P<0.04).
DISCUSSION
Echinacea tablets have been marketed in Serbia 
as a herbal remedy. Previous studies with Echinacea 
preparations suggest that these products, possess 
antioxidative properties thanks to high phenolic 
content (11, 12). We based our dosage on earlier 
studies which used Echinacea at relatively low doses, 
lower than those used by many practicing herbalists 
(12). 
Our group of ten volunteers was rather homogenous 
in age and occupational exposure duration. All were 
radiology department technicians of the City Clinical 
Hospital applying diagnostic procedures. During 
the last ﬁ ve years none exceeded the annual limit of 
20 mSv. Six smoked, while the rest did not (see Table 
1). The highest frequency of chromosomal aberrations 
was found in two nonsmokers and in one smoker. 
After the two-week treatment, tests have shown a 
significantly reduced frequency of chromosomal 
aberrations and micronuclei in nine of the 10 subjects, 
whereas leukocyte count decreased, but remained 
normal. The absolute granulocyte count dropped and 
monocyte count increased. The percentage of apoptotic 
cells also increased; it was 53.5 % (SD=25.26) before 
and 61.36 % (SD=23.36) after the treatment.
Furthermore, the two-week treatment with 
Echinacea purpurea restored a balance between 
haematological parameters. Echinacea owes its 
powerful radioprotective effects to the scavenging 
capacity of phenolic compounds caffeic acid, cichoric 
acid, and echinacoside. Earlier findings of the 
beneﬁ cial effects of natural phenolic compounds have 
shown that they possess stronger antioxidant capacity 
than vitamins (13). The radioprotective properties of 
medicinal plants such as Podophyllum hexandrum, 
Ocimum sanctum, Ginko biloba, and Mentha piperita 
have been attributed to the presence of polyphenols 
capable to stop propagation steps of lipid peroxidation 
and chelate transitional metal ions, and hence to inhibit 
free radical formation (14).
Biologically active compounds of Echinacea 
reduce the yield of radiation-induced micronuclei, 
mainly by stimulating apoptosis, which is a radio-
recovery effect. This effect is important, particularly 
for long-lived chromosomal aberrations, which 
could lead to the overexpression of oncogenes and to 
cancer development. Echinacea enhances apoptosis 
of irradiated cells as a physiological mechanism with 
no inﬂ ammation, which looks promising for helping 
recovery after irradiation.
Adverse health effects of ionising radiation are 
still closely investigated. Radiation can activate 
oncogenes through a number of mechanisms including 
point mutation, chromosomal rearrangement, or 
chromosomal translocations. If irradiation results 
in the loss of a tumour suppressor gene, then it may 
become conducive to the expression of a malignant 
phenotype. Chromosomal aberrations in peripheral 
lymphocytes were found to be an intermediate endpoint 
in carcinogenesis (15, 16). The study of Bonassi et 
al. (17) has also shown that a higher micronucleus 
frequency may also be related to overall genetic 
instability and is predictive of cancer proneness. Low 
doses of ionising radiation induce oxidative stress 
which can signiﬁ cantly modulate some transcription 
factors. Once activated, these transcription factors 
might drive transcription of survival-related proteins. 
For instance, ionising radiation modulates more 
than 100 genes in human endothelial cells, causing 
up-regulation of genes involved in coagulation and 
peroxidase activity (18). It also triggers signals that 
mobilise innate and adaptive immune systems to deal 
with the intrusion and repair tissue. Little is known 
about the role of signals in tissue responses to this 
agent. This signal could mediate the pathogenesis of 
or recovery from radiation damage and alter intrinsic 
cellular radiosensitivity (19). A number of healthy 
individuals (10 % to 15 %) exhibit reduced (65 % 
to 80 % of normal) repair capacity phenotypes (20). 
These damage-specific phenotypes are heritable 
traits associated with increased radiosensitivity. It 
is estimated that every individual will be a variant 
for 6 to 8 genes in both base excision repair and 
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double-strand break repair pathways, whose primary 
responsibility is to repair DNA damage induced by 
ionising radiation (21). One of the most important 
recently studied genes is the Nijmegen breakage 
syndrome (NBS1) gene. While NBS is a rare disease, 
it is estimated that a signiﬁ cant proportion of the 
population may be heterozygous at this locus and 
be sensitive to radiation, even though they belong to 
“normal” population. NBS heterozygous individuals 
may be particularly susceptible to environmental, 
diagnostic, or therapeutic exposure to ionising 
radiation. Furthermore, heterozygous individuals 
may run an increased risk from ionising radiation at 
doses that are below the current workplace exposure 
limits.
Biologically active compounds from the Echinacea 
species are reported to possess immunomodulatory 
properties such as enhancement of monocyte-
macrophage activity (22). In our study, monocyte 
count and apoptotic ability of leukocytes clearly 
increased, which is attributed to the Echinacea 
treatment.
Further investigation of common polymorphisms 
at relevant genes in humans would single out reagents 
for cellular biology experiments and molecular 
epidemiological studies employing a genotype-to-
phenotype/health consequence paradigm and reﬁ ne 
risk estimates associated with exposure to low-level 
ionising radiation. Understanding radiation effects 
in terms of coordinated multicellular responses that 
affect cellular fate may necessitate re-evaluation of 
radiation dose and risk concepts and provide avenues 
for intervention.
CONCLUSION
Administration of Echinacea purpurea preparation 
significantly reduces the incidence of radiation-
induced chromosomal aberrations and micronuclei 
in human lymphocytes of radiation workers. Its 
powerful radioprotective capacities are achieved 
through free radical scavenging performed by 
polyphenols, which stimulate apoptosis and enhance 
monocyte-macrophage activity. Echinacea purpurea 
posseses remarkable protective properties and its 
biological activity could be important for many other 
diseases where lipid peroxidation products have been 
reported.
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Sažetak
BIOLOŠKI UČINCI ECHINACEA PURPUREA NA KRVNE STANICE LJUDI
Cilj ovog rada je utvrđivanje radioprotektivnih svojstava Echinacea purpurea (“Ehinacea”, Strong Nature, 
Srbija) in vivo. Analizirani su kromosomske aberacije, mikronukleusi, apoptoza leukocita i hematološki 
parametri u skupini ispitanika profesionalno izloženih ionizirajućem zračenju u čijim je limfocitima utvrđena 
prisutnost dicentričnih kromosoma. Sve osobe profesionalno izložene ionizirajućem zračenju su uzimale 4 
“Echinacea” tablete na dan, prema preporučenoj ljekarničkoj dozi. Svi parametri su analizirani na početku 
i nakon dva tjedna tretmana. Na kraju studije učestalost kromosomskih aberacija u limfocitima značajno 
je smanjena, dok je apoptotski potencijal leukocita povećan. Omjer limfocita i granulocita utvrđen na 
početku studije nakon dva tjedna je dostigao normalne vrijednosti. Uočena svojstva Echinacea purpurea 
mogu biti važna u prevenciji i ublažavanju učinaka štetnih za zdravlje.
KLJUČNE RIJEČI: apoptoza, in vivo, ionizirajuće zračenje, mikronukleusi, protektivni učinci
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